Suppr超能文献

2019年冠状病毒病(COVID-19)的神经学特征:系统评价与荟萃分析

Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis.

作者信息

Pinzon Rizaldy Taslim, Wijaya Vincent Ongko, Buana Ranbebasa Bijak, Al Jody Abraham, Nunsio Patrick Nalla

机构信息

Faculty of Medicine, Duta Wacana Christian University, Yogyakarta, Indonesia.

Bethesda Hospital, Yogyakarta, Indonesia.

出版信息

Front Neurol. 2020 May 29;11:565. doi: 10.3389/fneur.2020.00565. eCollection 2020.

Abstract

Coronavirus disease 2019 (COVID-19) is a newly emerging infectious disease that has caused a global pandemic. The presenting symptoms are mainly respiratory symptom, yet studies have reported nervous system involvement in the disease. A systematic review and meta-analysis of these studies are required to understanding the neurologic characteristic of the disease and help physicians with early diagnosis and management. To conduct a systematic review and meta-analysis on the neurologic characteristics in patients with COVID-19. Authors conducted a literature search through PubMed from January 1st, 2020 to April 8th, 2020. Furthermore, the authors added additional sources by reviewing related references. Studies presenting the neurologic features of COVID-19 patients in their data were included. Case reports and case series were also included in this review. The quality of the studies was assessed based on the Oxford Center for Evidence-Based Medicine guidelines. Selected studies were included in the meta-analysis of proportion and the heterogeneity test. From 280 identified studies, 33 were eligible, with 7,559 participants included. Most of the included studies were from China (29 [88%]). Muscle injury or myalgia was the most common (19.2%, 95%CI 15.4-23.2%) neurologic symptom of COVID-19, followed by headache (10.9%, 95%CI 8.62-13.51%); dizziness (8.7%, 95%CI 5.02-13.43%); nausea with or without vomiting (4.6%, 95%CI 3.17-6.27%); concurrent cerebrovascular disease (4.4%, 95%CI 1.92-7.91%); and impaired consciousness (3.8%, 95%CI 0.16-12.04%). Underlying cerebrovascular disease was found in 8.5% (95%CI 4.5-13.5%) of the studies. Neurologic findings vary from non-specific to specific symptoms in COVID-19 patients. Some severe symptoms or diseases can present in the later stage of the disease. Physicians should be aware of the presence of neurologic signs and symptoms as a chief complaint of COVID-19, in order to improve management and prevent a worsening outcome of the patients.

摘要

2019冠状病毒病(COVID-19)是一种新出现的传染病,已引发全球大流行。其呈现的症状主要为呼吸道症状,但已有研究报道该疾病存在神经系统受累情况。需要对这些研究进行系统评价和荟萃分析,以了解该疾病的神经学特征,并帮助医生进行早期诊断和管理。为了对COVID-19患者的神经学特征进行系统评价和荟萃分析,作者于2020年1月1日至2020年4月8日通过PubMed进行了文献检索。此外,作者通过查阅相关参考文献补充了其他来源。纳入了在数据中呈现COVID-19患者神经学特征的研究。本评价还纳入了病例报告和病例系列。根据牛津循证医学中心指南对研究质量进行评估。将选定的研究纳入比例的荟萃分析和异质性检验。在280项已识别的研究中,33项符合条件,共纳入7559名参与者。纳入的研究大多来自中国(29项[88%])。肌肉损伤或肌痛是COVID-19最常见的神经学症状(19.2%,95%置信区间15.4 - 23.2%),其次是头痛(10.9%,95%置信区间8.62 - 13.51%);头晕(8.7%,95%置信区间5.02 - 13.43%);伴有或不伴有呕吐的恶心(4.6%,95%置信区间3.17 - 6.27%);并发脑血管疾病(4.4%,95%置信区间1.92 - 7.91%);以及意识障碍(3.8%,95%置信区间0.16 - 12.04%)。在8.5%(95%置信区间4.5 -

13.5%)的研究中发现了潜在的脑血管疾病。COVID-19患者的神经学表现从非特异性症状到特异性症状各不相同。一些严重症状或疾病可能在疾病后期出现。医生应意识到神经体征和症状作为COVID-19主要主诉的存在,以便改善管理并防止患者病情恶化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b65/7273516/b5afc57fe17a/fneur-11-00565-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验